References
- Hersh DS, Harder BG, Roos A, et al. TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Neuro Oncol. 2018;20:1321–1330.
- Delgado-Martín B, Medina MÁ. Advances in the knowledge of the molecular biology of glioblastoma and its impact in patient diagnosis, stratification, and treatment. Adv Sci (Weinh). 2020;7:1902971.
- Le Rhun E, Preusser M, Roth P, et al. Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 2019;80:101896.
- Lucero R, Zappulli V, Sammarco A, et al. Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells. Cell Rep. 2020;30:2065–2074.e4.
- Jiang XH, Liu YY. LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p. Eur Rev Med Pharmacol Sci. 2020;24:766–772.
- Jiang L, Wang C, Lei F, et al. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway. Oncotarget. 2015;6:8286–8299.
- Tan Y, Huang N, Zhang X, et al. KIAA0247 suppresses the proliferation, angiogenesis and promote apoptosis of human glioma through inactivation of the AKT and Stat3 signaling pathway. Oncotarget. 2016;7:87100–87113.
- Cai Z, Cao Y, Luo Y, et al. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumor therapeutic resistance. Clin Chim Acta. 2018;483:156–163.
- Pang H, Zheng Y, Zhao Y, et al. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun. 2015;468:739–745.
- Zhang X, Wei C, Li J, et al. MicroRNA-194 represses glioma cell epithelial-to-mesenchymal transition by targeting Bmi1. Oncol Rep. 2017;37:1593–1600.
- Tian Y, Nan Y, Han L, et al. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol. 2012;40:1105–1112.
- Nan Y, Han L, Zhang A, et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010;1359:14–21.
- Nan Y, Guo H, Guo L, et al. MiRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1α/VEGF signaling pathway by targeting CAB39. Hum Gene Ther Clin Dev. 2018;29:156–166.
- Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9:317–324.
- Liu L, Hu J, Yu T, et al. miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway. Acta Biochim Biophys Sin (Shanghai). 2019;51:492–500.
- Zhao K, Wang L, Li T, et al. The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required. Int J Oncol. 2017;50:1989–1999.
- Zeng T, Peng L, Chao C, et al. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Int J Clin Exp Pathol. 2014;7:7653–7662.
- Liu T, Wu X, Li Y, et al. RBFOX3 regulates the chemosensitivity of cancer cells to 5-fluorouracil via the PI3K/AKT, EMT and cytochrome-C/caspase pathways. Cell Physiol Biochem. 2018;46:1365–1380.
- Li C, Ao H, Chen G, et al. The Interaction of CDH20 with β-Catenin inhibits cervical cancer cell migration and invasion via TGF-β/Smad/SNAIL mediated EMT. Front Oncol. 2020;9:1481.
- Zhu H, Chen Z, Shen L, et al. Long noncoding RNA LINC-PINT suppresses cell proliferation, invasion, and EMT by blocking Wnt/β-Catenin signaling in glioblastoma. Front Pharmacol. 2021;11:586653.
- Zhang Q, Yang L, Guan G, et al. LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT. Front Oncol. 2020;10:569584.
- Srivastava C, Irshad K, Dikshit B, et al. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Int J Cancer. 2018;142:805–812.